P2.18-04 Real-world Study on Efficacy of First-Line Nivolumab + Ipilimumab in Unresectable Malignant Pleural Mesothelioma (ImmunoMeso)

Details

Language :

English

ISSN :

15560864 and 15561380

Volume :

18

Issue :

11, Number 11 Supplement 1

Database :

Supplemental Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Periodical

Accession number :

ejs64381904

Full Text :

https://doi.org/10.1016/j.jtho.2023.09.677